Covid vaccine maker BioNTech reports £972m profit in first quarter

A member of staff uses a needle and a phial of Pfizer/BioNTech Covid-19 vaccine (Justin Tallis/PA)
A member of staff uses a needle and a phial of Pfizer/BioNTech Covid-19 vaccine (Justin Tallis/PA)

Already a subscriber? Sign in

[[title]]

[[text]]